Cart
sales@molnova.com
PNU-282987 S enantiomer free base?
CAS No. 737727-12-7
PNU-282987 S enantiomer free base?( —— )
Catalog No. M20986 CAS No. 737727-12-7
PNU-282987 S enantiomer free base is an agonist of α7 nicotinic acetylcholine receptor (α7 nAChR).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 312 | Get Quote |
|
| 5MG | 530 | Get Quote |
|
| 10MG | 758 | Get Quote |
|
| 25MG | 1152 | Get Quote |
|
| 50MG | 1557 | Get Quote |
|
| 100MG | 2097 | Get Quote |
|
| 500MG | 4203 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamePNU-282987 S enantiomer free base?
-
NoteResearch use only, not for human use.
-
Brief DescriptionPNU-282987 S enantiomer free base is an agonist of α7 nicotinic acetylcholine receptor (α7 nAChR).
-
DescriptionPNU-282987 S enantiomer free base is an agonist of α7 nicotinic acetylcholine receptor (α7 nAChR).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayEndocrinology/Hormones
-
TargetAChR
-
Recptorα7 nAChR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number737727-12-7
-
Formula Weight264.75
-
Molecular FormulaC14H17ClN2O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(N[C@@H]1CN2CCC1CC2)c1ccc(Cl)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Bodnar A L Cortes-Burgos L A Cook K K et al. Discovery and Structure?Activity Relationship of Quinuclidine Benzamides as Agonists of 伪7 Nicotinic Acetylcholine Receptors[J]. Journal of Medicinal Chemistry 2005 48(4):905-908.
molnova catalog
related products
-
Forskolin
Forskolin is a ubiquitous activator of eukaryotic adenylyl cyclase (AC) in a wide variety of cell types, commonly used to raise levels of cAMP in the study and research of cell physiology.
-
Pirenzepine dihydroc...
An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function.
-
GZD 824
GZD824 is an orally bioavailable Bcr-Abl inhibitor for Bcr-Abl(WT, IC50: 0.34 nM) and Bcr-Abl(T315I, IC50: 0.68 nM).
